Dr. Arash Vahdat, MD

Dr. Vahdat practices at Center for Fertility and Gynecology in Tarzana, California.

Dr. Vahdat's NPI, 1225134232, was assigned on September 16, 2006. Dr. Vahdat graduated from SUNY Downstate Health Sciences University in 1999. Dr. Vahdat holds California license A73458.

Dr. Vahdat's primary practice is Center for Fertility and Gynecology, at 18370 W Burbank Blvd, Tarzana, CA 91356 in Los Angeles County. The practice phone is (818) 986-1070.

Dr. Vahdat's primary practice is Center for Fertility and Gynecology in Tarzana, California. Dr. Vahdat is also affiliated with Providence Cedars-Sinai Tarzana Medical Center. Dmand AI also links Dr. Vahdat to 4 more hospitals, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vahdat practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Vahdat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Vahdat is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Vahdat's licenses on file in 2 states: California and Idaho.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Vahdat treats.

CMS data shows 12,078 Medicare services from Dr. Vahdat across 39 procedure codes in 2024, for 1,709 Medicare patients. Medicare paid $806,563 for them.

CMS counts 1,709 Medicare patients who saw Dr. Vahdat in 2024. The largest group is 65 to 74, with 618 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vahdat's median patient age at 67, with 47% women.

In 2024, Dr. Vahdat wrote 7,730 Medicare Part D claims for 618 patients. 76% of them were for generic drugs. CMS names the drug for 7,536 of them, across 65 drugs with 11 or more claims each, at $1,438,222 in total drug cost. In 2023, CMS named 7,352 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vahdat for performance year 2024, reported individually. Dr. Vahdat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vahdat as offering telehealth. CMS counts 100 procedures of coronary angioplasty and stenting by Dr. Vahdat, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Vahdat in 2022. The most frequent topics are Echocardiography. Dr. Vahdat has published most often in Echocardiography. Dr. Vahdat's most frequent co-authors are Amanda Michael Donohue, DO, Thomas Arthur Gibbs, DO and Omid Vahdat, MD.

Dmand AI links Dr. Vahdat to 1 clinical trial. Conditions studied include Anemia, Iron-Deficiency and Anemia, Hypochromic.

CMS Open Payments shows 1,287 general payments to Dr. Vahdat from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Amgen Inc. paid the most, $98,617. It also lists 1 research payment totaling $16 in 2016.

Dr. Vahdat graduated from SUNY Downstate Health Sciences University in 1999.

Dr. Vahdat is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.